ML1808 is an intranasal anti-Alzheimer drug. It suppresses not only Aβ oligomer but also tau oligomer and oxifative stress by using 2 active ingredients: rifampicin(RFP) and compound X. アルツハイマー病発症予防点鼻薬 〜既に安全性が確認された2つの有効成分により実現へ